ADB approves US $ 1.5 bn for Covid-19 vaccines in India
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The NFI is published to promote the rational use of medicines in the country.
Acute therapies continue to report strong growth compared to chronic ones.
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Subscribe To Our Newsletter & Stay Updated